BUZZ-IMUNON 因计划将资源转移到卵巢癌治疗而上涨

路透中文
Feb 05
BUZZ-IMUNON 因计划将资源转移到卵巢癌治疗而上涨

2月5日 - ** 生物技术公司IMUNON IMNN.O股价上涨2%至3.17美元

** 该公司称 (link),它将裁员并减少开支,以将更多资源投入到其针对卵巢癌药物IMNN-001的后期临床试验中。

** 卵巢癌通常发现较晚;该公司的实验性疗法旨在增强人体对肿瘤部位的免疫反应 - IMNN

** 公司称其晚期试验正在提前招募患者

** 最近的中期数据显示,据该公司称,IMNN-001 加标准化疗可使患者的中位生存期延长 13 个月。

** 公司称首席科学官 安维尔(Khursheed Anwer) 将于 2 月 20 日退休

** 2025 年股价上涨约 93%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10